"Beriberi" Interesting!

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 12, 2003, Pages 924-926

  Cole, Peter D ^a,b   Kamen, Barton A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCARBOXYLASE; CYTARABINE; FOLIC ACID DERIVATIVE; METHOTREXATE; REDUCED FOLATE CARRIER; THIAMINE; VINCA ALKALOID; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; BERIBERI; CLINICAL FEATURE; DISEASE COURSE; DRUG MEGADOSE; HUMAN; NEUROTOXICITY; NOTE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; THIAMINE DEFICIENCY;

BERIBERI; HUMANS; MEMBRANE TRANSPORT PROTEINS; METHOTREXATE; VARIATION (GENETICS); VINCRISTINE;

EID: 0347384008     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200312000-00002     Document Type: Note

References (27)

1. Talbott JH. A Biographical History of Medicine: Excerpts and Essays on the Men and Their Work. New York: Grune & Stratton, 1970
2. Vasconcelos MM, Silva KP, Vidal G, et al. Early diagnosis of pediatric Wernicke's encephalopathy. Pediatr Neurol. 1999;20:289-294.
3. Bruck W, Christen HJ, Lakomek H, et al. Wernicke's encephalopathy in a child with acute lymphoblastic leukemia treated with polychemotherapy. Clin Neuropathol. 1991;10:134-136.
4. Diaz GA, Banikazemi M, Oishi K, et al. Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. Nat Genet. 1999;22:309-312.
5. Kalmanchey R, Koos R, Majtenyi K, et al. Wernicke-encephalopathy in children with cancer. Med Pediatr Oncol. 1994;22:133-136.
6. Kitamura K, Takahashi T, Tanaka H, et al. Two cases of thiamine deficiency-induced lactic acidosis during total parenteral nutrition. Tohoku J Exp Med. 1993;171:129-133.
7. Miyajima Y, Fukuda M, Kojima S, et al. Wernicke's encephalopathy in a child with acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol. 1993;15:331-334.
8. Oriot D, Wood C, Gottesman R, et al. Severe lactic acidosis related to acute thiamine deficiency. JPEN J Parenteral Enteral Nutr. 1991;15: 105-109.
9. Rovelli A, Bonomi M, Murano A, et al. Severe lactic acidosis due to thiamine deficiency after bone marrow transplantation in a child with acute monocytic leukemia. Haematologica. 1990;75:579-581.
10. Sawada M, Tsurumi H, Hara T, et al. Graft failure of autologous peripheral blood stem cell transplantation due to acute metabolic acidosis associated with total parenteral nutrition in a patient with relapsed breast cancer. Acta Haematol. 2000;102:157-159.
11. Seligmann H, Levi R, Konijn AM, et al. Thiamine deficiency in patients with B-chronic lymphocytic leukaemia: a pilot study. Postgrad Med J. 2001;77:582-585.
12. Shah N, Wolff JA. Thiamine deficiency: probable Wernicke's encephalopathy successfully treated in a child with acute lymphocytic leukemia. Pediatrics. 1973;51:750-751.
13. Ulusakarya A, Vantelon JM, Munck JN, et al. Thiamine deficiency in a patient receiving chemotherapy for acute myeloblastic leukemia. Am J Hematol. 1999;61:155-156.
14. van Zaanen HC, van der Lelie J. Thiamine deficiency in hematologic malignant tumors. Cancer. 1992;69:1710-1713.
15. Yip SF, Yeung YM, Tsui EY. Severe neurotoxicity following arsenic therapy for acute promyelocytic leukemia: potentiation by thiamine deficiency. Blood. 2002;99:3481-3482.
16. Legha SS. Vincristine neurotoxicity. Pathophysiology and management. Med Toxicol. 1986;1:421-427.
17. Quinn CT, Kamen BA. A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities. J Investig Med. 1996;44:522-530.
18. Baker WJ, Royer GL Jr, Weiss RB. Cytarabine and neurologic toxicity. J Clin Oncol. 1991;9:679-693.
19. Dutta B, Huang W, Molero M, et al. Cloning of the human thiamine transporter, a member of the folate transporter family. J Biol Chem. 1999;274: 31925-31929.
20. Zhao R, Gao F, Goldman ID. Reduced folate carrier transports thiamine monophosphate: an alternative route for thiamine delivery into mammalian cells. Am J Physiol Cell Physiol. 2002;282:C1512-C1517.
21. Zhao R, Gao F, Wang Y, et al. Impact of the reduced folate carrier on the accumulation of active thiamin metabolites in murine leukemia cells. J Biol Chem. 2001;276:1114-1118.
22. Whetstine JR, Flatley RM, Matherly LH. The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter. Biochem J. 2002;367:629-640.
23. Fodinger M, Skoupy S, Sunder-Plassmann G. Molecular genetics of folate metabolism. In: Massaro EJ, Rogers JM, eds. Folate and Human Development. Totowa, NJ: Humana Press, 2002:91-115
24. Zhao R, Assaraf YG, Goldman ID. A reduced folate carrier mutation produces substrate-dependent alterations in carrier mobility in murine leukemia cells and methotrexate resistance with conservation of growth in 5-formyltetrahydrofolate. J Biol Chem. 1998;273:7873-7879.
25. McCool BA, Plonk SG, Martin PR, et al. Cloning of human transketolase cDNAs and comparison of the nucleotide sequence of the coding region in Wernicke-Korsakoff and non-Wemicke-Korsakoff individuals. J Biol Chem. 1993;268:1397-1404.
26. Martin PR, McCool BA, Singleton CK. Molecular genetics of transketolase in the pathogenesis of the Wemicke-Korsakoff syndrome. Metab Brain Dis. 1995;10:45-55.
27. Henderson GB, Zevely EM. Structural requirements for anion substrates of the methotrexate transport system in L1210 cells. Arch Biochem Biophys. 1983;221:438-446.